Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating INFINITIVE immunotherapy for metastatic colorectal cancer with liver metastases, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFINITIVE

Snippet

Sponsor: Northwell Health | Conditions: Colorectal Cancer Metastatic | EARLY_Phase 1 | Status: RECRUITING